Οστεονέκρωση Γνάθων (MRONJ): Από τη Θεωρία στην Πράξη - 3ο Webinar Εξειδίκευσης

What Happened in the Previous Webinars?

On January 16, 180 dentists attended the first webinar.

On February 6, 174 dentists attended the second webinar — with over 100 clinical questions submitted in the chat.

Total: 354 dentists in just 2 months.

The response was immediate:

“The STEPS and their evaluation for our treatment planning were extremely useful!”

“A very useful seminar! For the first time, I clearly understand when it is safe to proceed.”

“The most practical webinar I have ever attended. Concrete protocols, not generalities.”

“You are always so supportive! We need more seminars like this.”

We listened to your questions.
We understood your needs.

And we designed the next step.

What Has Changed Compared to the Previous Webinars?

1st Webinar:
You were given the system — the risk assessment table, the 3 risk levels, and the core approach.

2nd Webinar:
You were given the application — how to use it with your own patients, through real clinical cases.

3rd Webinar:
You are given the advanced tools — drug-specific protocols (denosumab vs bisphosphonates), edge cases, and comprehensive legal documentation.

From theory → to practice → to excellence.

Who Is This Webinar For?

The 3rd webinar is ideal for dentists who:

✅ Attended the previous webinars and want to go deeper
✅ Already manage patients on antiresorptive therapy and need drug-specific guidance
✅ Hesitate to proceed with extractions or treatment due to fear
✅ Want comprehensive legal documentation to protect their practice
✅ Deal with complex cases involving multiple risk factors

Didn’t attend the previous webinars?
No worries — we will provide a brief recap of the essentials.

Speakers

Professor Ourania Nicolatou-Galitis
Internationally awarded expert in Medication-Related Osteonecrosis of the Jaw (MRONJ),
Member of the European Expert Panel on MRONJ and former President of the MASCC/ISOO Bone Study Group.

Dr. Dimitra Galiti
PhD in Oral Diagnostic & Radiology (National and Kapodistrian University of Athens),
MSc in Forensic Odontology (KU Leuven),
Recipient of the MASCC/ISOO Young Investigator Award.

What Will Be Covered in the Webinar

1. Quick Review: The 3-Step MRONJ System

A fast overview of the risk assessment table (green–yellow–red) for those who did not attend the previous webinars.

2. Drug-Specific Protocols: Denosumab vs Bisphosphonates

Why these cannot be managed the same way:

Denosumab: half-life, rebound effect, drug-holiday strategy
Bisphosphonates: bone accumulation, cumulative exposure
Case studies for each drug

3. Advanced Surgical Protocols

Beyond “atraumatic extraction”:

Pre-operative preparation (oncologist communication, prophylaxis)
Surgical technique — the 7 critical steps
Complication management
Video demonstration (de-identified case)

4. Edge Cases & Complex Scenarios

What to do when:

Multiple risk factors (denosumab + corticosteroids + smoking)
History of radiation therapy + antiresorptives
Emergency situations in high-risk patients
Existing MRONJ: staging & management

5. Comprehensive Legal Documentation

Documentation that protects you:

MRONJ Risk Assessment Form
MRONJ-specific Informed Consent
Communication with the treating oncologist (template letters)
Best practices for clinical notes

6. Live Q&A Session – Bring Your Own Cases

Submit questions about your own patients (anonymously).

What You Will Take With You

✅ Drug-specific protocols for denosumab vs bisphosphonates
✅ Advanced surgical techniques
✅ Edge-case management strategies
✅ Complete legal documentation toolkit (4 editable forms)
✅ Confidence in managing challenging cases
✅ Recording access for 48 hours

Participants attending live will also receive information about the MRONJ Mastery comprehensive training program, launching in May 2026.

Date: April 2026
Time: 10:00–12:15
Live via Zoom

🎯 Limited seats (max 200 participants)
🎯 Zoom link sent 24 hours before the webinar
🎯 Recording available for 48 hours, for registered participants only

News > Advanced protocols for the management of high-risk patients